Source:http://linkedlifedata.com/resource/pubmed/id/12215016
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2002-9-6
|
pubmed:abstractText |
Primary effusion lymphoma (PEL) is recognized as a unique lymphoma entity, which occurs exclusively in body cavities as a serous lymphomatous effusion without tumor formation or organ infiltration. We established a cell line of B-cell origin from a pericardial effusion of a 63-year-old Japanese PEL patient who did not have human immunodeficiency virus infection. This PEL cell line had human herpesvirus-8 (HHV-8) and Epstein-Barr virus (EBV) infection. We named this cell line RM-P1. This cell line showed complex chromosomal abnormalities that could not be identified by G-banding. However, spectral karyotyping analysis determined the origin and organization of all unidentified chromosomal abnormalities. When inoculated into the peritoneal cavity of 8 severe combined immunodeficiency (SCID) mice depleted of natural killer cells, RM-P1 cells induced solid tumor with ascites in all animals tested. These tumor and ascitic cells had the same immunogenotypic features as those of the original RM-P1. These 2 types of cells were positive for both HHV-8 and EBV as demonstrated using polymerase chain reaction. Fluorescence-activated cell sorting analyses showed that neither tumors nor ascitic cells grown in SCID mice expressed leukocyte function-associated antigen (LFA)-1alpha (CD11a), LFA-1lbeta (CD18), LFA-2 (CD2), LFA-3 (CD58), intercellular adhesion molecule (ICAM)-1 (CD54), ICAM-2 (CD102), ICAM-3 (CD50), or leukocyte endothelial adhesion molecule (LECAM)-1 (CD62L), suggesting that these cytoadhesion molecules are not involved in tumor formation of RM-P1 cells in vivo. The establishment of the RM-P1 cell line and the animal model of PEL may provide insights for understanding the relationship between these viruses and PEL and for understand the mechanism for PEL.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0925-5710
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
76
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
165-72
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:12215016-Animals,
pubmed-meshheading:12215016-Cell Adhesion Molecules,
pubmed-meshheading:12215016-Cell Division,
pubmed-meshheading:12215016-Herpesvirus 4, Human,
pubmed-meshheading:12215016-Herpesvirus 8, Human,
pubmed-meshheading:12215016-Humans,
pubmed-meshheading:12215016-Karyotyping,
pubmed-meshheading:12215016-Lymphoma,
pubmed-meshheading:12215016-Male,
pubmed-meshheading:12215016-Mice,
pubmed-meshheading:12215016-Mice, SCID,
pubmed-meshheading:12215016-Middle Aged,
pubmed-meshheading:12215016-Neoplasm Transplantation,
pubmed-meshheading:12215016-Pleural Effusion, Malignant,
pubmed-meshheading:12215016-Tumor Cells, Cultured
|
pubmed:year |
2002
|
pubmed:articleTitle |
Establishment of a primary effusion lymphoma cell line (RM-P1) and in vivo growth system using SCID mice.
|
pubmed:affiliation |
Second Department of Internal Medicine, Faculty of Medicine, University of the Ryukus, Nishihara, Okinawa, Japan. mygj1@lime.ocn.ne.jp
|
pubmed:publicationType |
Journal Article
|